UA137076U - COMPOSITION FOR TREATMENT OF ORAL AND THROAT CAVITY - Google Patents

COMPOSITION FOR TREATMENT OF ORAL AND THROAT CAVITY

Info

Publication number
UA137076U
UA137076U UAU201904169U UAU201904169U UA137076U UA 137076 U UA137076 U UA 137076U UA U201904169 U UAU201904169 U UA U201904169U UA U201904169 U UAU201904169 U UA U201904169U UA 137076 U UA137076 U UA 137076U
Authority
UA
Ukraine
Prior art keywords
treatment
composition
oral
throat cavity
methyl
Prior art date
Application number
UAU201904169U
Other languages
Ukrainian (uk)
Inventor
Володимир Антонович Загорій
Original Assignee
Володимир Антонович Загорій
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Володимир Антонович Загорій filed Critical Володимир Антонович Загорій
Priority to UAU201904169U priority Critical patent/UA137076U/en
Publication of UA137076U publication Critical patent/UA137076U/en

Links

Landscapes

  • Cosmetics (AREA)

Abstract

Композиція для лікування захворювань ротової порожнини містить як допоміжні речовини - гексетидин, холіну саліцилат, хлорбутанолу гемігідрат, як розчинник та консервант - етанол, як підсолоджувач - сахарин натрію, як емульгатор - полісорбат 20, як ароматизатори - суміш олій, метилсаліцилат, левоментол, як корелятор рН - кислоту лимонну моногідрат, воду очищену.The composition for the treatment of diseases of the oral cavity contains as excipients - hexetidine, choline salicylate, chlorobutanol hemihydrate, as a solvent and preservative - ethanol, as a sweetener - saccharin sodium, as an emulsifier - polysorbate 20, as a flavoring - a mixture of oils, methyl, methyl pH - citric acid monohydrate, purified water.

UAU201904169U 2019-04-19 2019-04-19 COMPOSITION FOR TREATMENT OF ORAL AND THROAT CAVITY UA137076U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201904169U UA137076U (en) 2019-04-19 2019-04-19 COMPOSITION FOR TREATMENT OF ORAL AND THROAT CAVITY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201904169U UA137076U (en) 2019-04-19 2019-04-19 COMPOSITION FOR TREATMENT OF ORAL AND THROAT CAVITY

Publications (1)

Publication Number Publication Date
UA137076U true UA137076U (en) 2019-09-25

Family

ID=74213668

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201904169U UA137076U (en) 2019-04-19 2019-04-19 COMPOSITION FOR TREATMENT OF ORAL AND THROAT CAVITY

Country Status (1)

Country Link
UA (1) UA137076U (en)

Similar Documents

Publication Publication Date Title
CL2022003510A1 (en) Cysteine protease inhibitors and their methods of use
CY1124404T1 (en) BILE ACID DERIVATIVES AS FXR/TGR5 AGENTS AND METHODS OF USING THEREOF
MX2021006421A (en) Amino-acid anilides as small molecule modulators of il-17.
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
EA201890767A1 (en) C4-MODIFIED OLEANOLIC ACID DERIVATIVES FOR INHIBITION OF IL-17 AND OTHER APPLICATIONS
NO20063693L (en) Connection and method of use
CR10614A (en) FUSIONED HETEROCICLIC DERIVATIVES AND METHODS OF USE
CO6290683A2 (en) HETEROCICLIC IMIDAZOLINE PIRIDO COMPOUNDS AND THEIR COMPOSITIONS AS C-MET INHIBITORS
MY194087A (en) Use of gabaa receptor reinforcing agent in preparation of sedative and anesthetic medicament
EA201100750A1 (en) SUBSTITUTED DIOXOPIPERIDINYL-PHTHALIMIDE DERIVATIVES
EA202092829A1 (en) CONTROLLED RELEASE TOPACITINIB COMPOSITIONS
CL2017003066A1 (en) Compositions of amorphous calcium carbonate for administration by inhalation, sublingual or buccal
EA202192900A1 (en) MODULATORS OF INTEGRATED STRESS RESPONSE PATHWAYS
HN2008001666A (en) ACID DERIVATIVES OF CICLOALQUILAMINO
SA521431279B1 (en) A substituted tetrahydroisoquinoline derivative as a d1 positive allosteric modulator
BR112013021566A2 (en) compound of formula, or a pharmaceutically acceptable salt or adduct thereof and method of preventing and / or treating an individual comprising administering to said individual a therapeutically effective amount of a compound of formula
EA202191955A1 (en) MODIFIED RELEASE TABLET FORMULATIONS CONTAINING PHOSPHODIESTERASE INHIBITORS
EA202091604A1 (en) INHIBITION OF THE ION CHANNEL A1 WITH A TRANSITOR RECEPTOR POTENTIAL
BRPI0517369A (en) compounds, process for their manufacture, compositions comprising them, method for the treatment and / or prophylaxis of diseases that are associated with modulation of cb1 receptors and their use
EA201991355A1 (en) IMIDAZO [1,5-A] PYRASINE DERIVATIVES AS PI3K DELTA INHIBITORS
MX2023001296A (en) Compositions and methods for treating diseases and disorders.
MA34746B1 (en) DIPHENYLAMINE DERIVATIVES: USES, METHODS OF SYNTHESIS, AND PHARMACEUTICAL COMPOSITIONS
UA137076U (en) COMPOSITION FOR TREATMENT OF ORAL AND THROAT CAVITY
EA201890616A1 (en) SULPHONAMIDE CONNECTIONS AS MODULATORS OF POTENTIALLY CONTROLLED SODIUM CHANNELS
ECSP099328A (en) PIRAZOL ANALOGS